JAGLX Mutual Fund
JAGLX Mutual Fund
JAGLX Mutual Fund
Janus Henderson Global Life Sciences Fund Class T
JAGLX Mutual Fund Overview
JAGLX Mutual Fund (Janus Henderson Global Life Sciences Fund Class T) is managed by Janus Henderson Investors with $1.41B in net assets. JAGLX expense ratio is 0.92%, holding 98 positions across sectors including Health Care, Financials. Inception date: 1998-12-31.
JAGLX performance shows a YTD return of 14.94%. The 1-year return is 25.49% and the 5-year return is 8.89%. JAGLX dividend yield stands at 3.94%, paid annually.
JAGLX top holdings include Eli Lilly & Co (9.1%), Johnson & Johnson - Common (7.5%), Abbvie Inc. (4.6%), Unitedhealth Group Incorporated (4.3%), AstraZeneca PLC (3.5%). Go to all JAGLX holdings, JAGLX sectors, or JAGLX dividends.
JAGLX can be compared against other funds. Use JAGLX overlap to find shared positions, or JAGLX vs another fund for a side-by-side view. JAGLX alternatives are available via the screener, along with tax-loss harvesting opportunities.